Shilpa Medicare Limited (BOM:530549)
India · Delayed Price · Currency is INR 550.70
+4.95 (0.91%)
At close: Jun 19, 2026
Shilpa Medicare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 15,389 | 12,864 | 11,516 | 10,501 | 11,455 |
Other Revenue | - | 15 | 15.04 | 15.65 | 14.11 |
| 15,389 | 12,879 | 11,531 | 10,517 | 11,469 | |
Revenue Growth (YoY) | 19.48% | 11.69% | 9.64% | -8.30% | 27.21% |
Cost of Revenue | 4,604 | 4,540 | 4,435 | 4,604 | 4,315 |
Gross Profit | 10,785 | 8,339 | 7,096 | 5,913 | 7,155 |
Selling, General & Admin | 3,349 | 2,987 | 2,855 | 2,965 | 2,782 |
Other Operating Expenses | 3,089 | 2,267 | 1,871 | 2,043 | 2,328 |
Operating Expenses | 7,635 | 6,385 | 5,805 | 5,967 | 5,950 |
Operating Income | 3,150 | 1,954 | 1,291 | -53.99 | 1,204 |
Interest Expense | -587.9 | -587.65 | -837.14 | -562.55 | -411.1 |
Interest & Investment Income | - | 80.32 | 13.81 | 17.61 | 20.67 |
Earnings From Equity Investments | 171.2 | -12.65 | -47.78 | -38.1 | -36.6 |
Currency Exchange Gain (Loss) | - | 131.19 | 84.42 | 140.12 | 66.58 |
Other Non Operating Income (Expenses) | 98.4 | -157.26 | -49.39 | 14.21 | 56.99 |
EBT Excluding Unusual Items | 2,832 | 1,408 | 455.31 | -482.7 | 900.61 |
Gain (Loss) on Sale of Investments | - | 38.71 | - | - | - |
Gain (Loss) on Sale of Assets | - | -2.71 | 5.44 | -2.65 | -16.02 |
Asset Writedown | -56.3 | -25 | - | - | - |
Other Unusual Items | 177.9 | -195.66 | 82.66 | 102.55 | 138.06 |
Pretax Income | 2,953 | 1,223 | 543.41 | -382.79 | 1,023 |
Income Tax Expense | 519.9 | 440.36 | 223.86 | -73.07 | 416.83 |
Earnings From Continuing Operations | 2,433 | 782.97 | 319.55 | -309.73 | 605.82 |
Minority Interest in Earnings | - | -0.04 | -0.81 | -15.6 | 0.8 |
Net Income | 2,433 | 782.93 | 318.74 | -325.33 | 606.62 |
Net Income to Common | 2,433 | 782.93 | 318.74 | -325.33 | 606.62 |
Net Income Growth | 210.79% | 145.63% | - | - | -58.95% |
Shares Outstanding (Basic) | 196 | 195 | 174 | 174 | 167 |
Shares Outstanding (Diluted) | 196 | 195 | 174 | 174 | 167 |
Shares Change (YoY) | 0.38% | 12.24% | - | 3.91% | 2.46% |
EPS (Basic) | 12.44 | 4.02 | 1.84 | -1.87 | 3.63 |
EPS (Diluted) | 12.44 | 4.02 | 1.83 | -1.88 | 3.63 |
EPS Growth | 209.61% | 118.96% | - | - | -59.95% |
Free Cash Flow | -284.5 | -1,115 | -478.92 | -467.44 | -2,267 |
Free Cash Flow Per Share | -1.45 | -5.72 | -2.76 | -2.69 | -13.57 |
Dividend Per Share | 0.600 | 0.500 | - | - | 0.550 |
Dividend Growth | 20.00% | - | - | - | - |
Gross Margin | 70.08% | 64.75% | 61.54% | 56.22% | 62.38% |
Operating Margin | 20.47% | 15.17% | 11.20% | -0.51% | 10.50% |
Profit Margin | 15.81% | 6.08% | 2.76% | -3.09% | 5.29% |
Free Cash Flow Margin | -1.85% | -8.65% | -4.15% | -4.45% | -19.77% |
EBITDA | 4,347 | 3,056 | 2,343 | 865.45 | 1,972 |
EBITDA Margin | 28.25% | 23.73% | 20.32% | 8.23% | 17.20% |
D&A For EBITDA | 1,197 | 1,102 | 1,052 | 919.44 | 768.03 |
EBIT | 3,150 | 1,954 | 1,291 | -53.99 | 1,204 |
EBIT Margin | 20.47% | 15.17% | 11.20% | -0.51% | 10.50% |
Effective Tax Rate | 17.61% | 36.00% | 41.20% | - | 40.76% |
Revenue as Reported | 15,487 | 13,096 | 11,598 | 10,675 | 11,598 |
Advertising Expenses | - | 45.6 | 28.68 | 26.23 | 56.59 |